Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development

Stock Information for Quotient Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quotient Limited

Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
Quotient Limited Announces Reverse Stock Split Effective Today
Quotient Limited Announces Intent to Effect Reverse Stock Split
Quotient Limited Selected to Join the World Economic Forum New Champions Community
Quotient Limited Expands MosaiQ Innovator's Circle to Empower Patient Care and Laboratory Efficiencies
Quotient Limited Provides First Quarter Fiscal 2023 Results and Business Update
Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.